CLLS
Cellectis S.A.
NASDAQ · Healthcare · Biotechnology · FR
$3.24
−2.41%Leverage
- Debt / equity
- 2.06x
- Net debt / equity
- 1.19x
- Debt / assets
- 0.32x
- Debt / EBITDA
- -1.52x
- Net debt / EBITDA
- -0.88x
Liquidity & coverage
- Current ratio
- 1.37x
- Quick ratio
- 1.37x
- Cash ratio
- 1.24x
- Interest coverage
- -7.35x
- EBITDA / interest
- -6.59x
- Working capital
- $49.5M
Cash & dividend
- FCF / debt
- -0.52x
- Cash flow / debt
- -0.50x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026